Belden Inc.: Form 10-Q for the period ended Oct 3, 2021
Filed with the SEC on Nov 8, 2021 and accepted by EDGAR at Nov 8, 2021, 14:03 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2021-10-03. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2021-07-05 to 2021-10-03 | $630.8m | us-gaap:Revenues |
| Revenue | 9 months2021-01-01 to 2021-10-03 | $1.77bn | us-gaap:Revenues |
| Cost of revenue | 3 months2021-07-05 to 2021-10-03 | $407.6m | us-gaap:CostOfGoodsAndServicesSold |
| Cost of revenue | 9 months2021-01-01 to 2021-10-03 | $1.14bn | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 3 months2021-07-05 to 2021-10-03 | $223.3m | us-gaap:GrossProfit |
| Gross profit | 9 months2021-01-01 to 2021-10-03 | $626.2m | us-gaap:GrossProfit |
| Research and development | 3 months2021-07-05 to 2021-10-03 | $32.5m | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 9 months2021-01-01 to 2021-10-03 | $94.9m | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 3 months2021-07-05 to 2021-10-03 | $110.0m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 9 months2021-01-01 to 2021-10-03 | $314.0m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months2021-07-05 to 2021-10-03 | $71.2m | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months2021-01-01 to 2021-10-03 | $188.6m | us-gaap:OperatingIncomeLoss |
| Income tax | 3 months2021-07-05 to 2021-10-03 | $8.9m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months2021-01-01 to 2021-10-03 | $25.3m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2021-07-05 to 2021-10-03 | $41.3m | us-gaap:NetIncomeLoss |
| Net income | 9 months2021-01-01 to 2021-10-03 | $113.7m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2021-07-05 to 2021-10-03 | $0.91 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 9 months2021-01-01 to 2021-10-03 | $2.51 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2021-07-05 to 2021-10-03 | $0.92 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 9 months2021-01-01 to 2021-10-03 | $2.54 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2021-07-05 to 2021-10-03 | 45,425,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 9 months2021-01-01 to 2021-10-03 | 45,242,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 9 months2021-01-01 to 2021-10-03 | $101.9m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 9 months2021-01-01 to 2021-10-03 | $55.6m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 9 months2021-01-01 to 2021-10-03 | $6.7m | us-gaap:PaymentsOfDividendsCommonStock |
| Cash and equivalents | At period end2021-10-03 | $457.8m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2021-10-03 | $1.27bn | us-gaap:AssetsCurrent |
| Total assets | At period end2021-10-03 | $3.34bn | us-gaap:Assets |
| Current liabilities | At period end2021-10-03 | $622.4m | us-gaap:LiabilitiesCurrent |
| Long-term debt | At period end2021-10-03 | $1.49bn | us-gaap:LongTermDebtNoncurrent |
| Shareholders' equity | At period end2021-10-03 | $939.5m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0000913142-21-000033. Last ingested by Listed: Oct 29, 2026, 14:50 ET. Listed shows no prices and gives no investment advice.